Skip to main content

Latest SEC Filings — Page 139

Most recent SEC EDGAR filings across all covered tickers, sorted chronologically. Wiseek AI reads each filing and scores it 1–10 for market-moving potential; click through for full analysis.

How Wiseek curates this list

Every filing on this page is sourced directly from SEC EDGAR, the U.S. Securities and Exchange Commission's public filings system. Wiseek processes 8-K, 10-K, 10-Q, Form 4, Form 144, DEF 14A, Schedule 13D/A and related disclosures filed by U.S.-listed companies. The original filing is always linked from each article so readers can verify the source document directly.

How filings get scored

Each filing runs through Wiseek's importance scorer, which weights filing type, deal magnitude, insider participation, material-event flags (going-concern, restatements, executive transitions, M&A) and historical market-reaction patterns. Filings scoring below 7 on the 1–10 scale are filtered out at the database query so this list stays focused on market-moving disclosures. See our methodology for the full rubric.

Editorial standards

Wiseek does not edit the underlying SEC filing. Plain-English summaries and key-event extractions are generated from the verified source text and clearly attributed as AI-generated. Wiseek does not provide investment advice — see our editorial policy for full standards on accuracy, source disclosure, and corrections.

Track by company

Follow all SEC filings for a specific company by visiting its ticker page: AAPL, MSFT, NVDA, TSLA, AMZN, GOOGL, META, JPM, V, UNH, XOM, AVGO, LLY, MA, COST, JNJ, PG, HD, ABBV, MRK, KO, NFLX, AMD, WMT, CVX, BAC — or browse all covered tickers.

XCF Global Q2 2026: Revenue Collapses 89%, Going Concern Doubt Reiterated, $238M Working Capital Deficit
ProForm 10-QSAFX · Form 10-Q · 2026-08-17
H World Q2 Revenue Up 10.8%, Raises Guidance, Announces $2.5B Return Plan
Form 6-KHTHT · Form 6-K · 2026-08-17
ORPATHYS plus TAGRISSO hits both PFS and OS endpoints in global Phase III SAFFRON trial
ProForm 6-KHCM · Form 6-K · 2026-08-17
FDCTech Q2 Revenue Jumps 222% to $17.5M; Reverse Split and Preferred Conversion Reshape Capital Structure
ProForm 10-QFDCT · Form 10-Q · 2026-08-17
Foresite Capital Reveals 14.5% Stake in Alumis Following IPO
Form SCHEDULE 13DALMS · Form SCHEDULE 13D · 2026-08-17
CEO Seto Wai Yue Buys 320,000 More Shares at $3.75, Lifting Stake to 32.99%
Form SCHEDULE 13D/ATDIC · Form SCHEDULE 13D/A · 2026-08-17
DataMeds AI Reports $26.1M Loss, Going Concern Doubt, and Nasdaq Equity Deficiency
ProForm 10-QMEDS · Form 10-Q · 2026-08-17
Centene CFO Andrew Asher to Retire; Christopher Neczypor Named Successor
Form 8-KCNC · Form 8-K · 2026-08-17
Interactive Strength Seeks Shareholder Approval for Massive Dilution and Reverse Split
ProForm DEF 14ATRNR · Form DEF 14A · 2026-08-17
Endeavour Silver Suspends Terronera Mine Operations Amid Illegal Blockade
ProForm 6-KEXK · Form 6-K · 2026-08-17
Valion Bio Terminates CEO, Appoints COO, and Secures $3M from Activist Investor
ProForm 8-KVBIO · Form 8-K · 2026-08-17
TTM Technologies Signs Definitive $1.1B All-Cash Deal to Acquire Epiq Solutions
ProForm 8-KTTMI · Form 8-K · 2026-08-17
Q2 Loss Narrows Dramatically, But Going Concern & Control Weaknesses Persist Amidst Crucial Financing
ProForm 10-QEMAT · Form 10-Q · 2026-08-17
CEO Seto Wai Yue Adds $1.2M Stake in Dreamland at $3.75, Now Holds 32.99%
ProForm 4/ATDIC · Form 4/A · 2026-08-17
AsiaStrategy Offloads ASTR Stake to Insiders for $10M, Citing Regulatory Burden
ProForm 6-KSORA · Form 6-K · 2026-08-17
Regen BioPharma Reports $239 Cash, Massive Dilution, and Going Concern Doubt
ProForm 10-QRGBP · Form 10-Q · 2026-08-17
Barrick-Newmont Nevada JV Agreement Finalized: $1.95B Cash Payment and Project Contributions
ProForm 6-KB · Form 6-K · 2026-08-17
Tower Semiconductor Posts Record Q2: Revenue Climbs 24%, Net Profit Doubles
ProForm 6-KTSEM · Form 6-K · 2026-08-17
Quince Therapeutics Files Pro Forma Financials for Series C Conversion Ahead of Special Meeting
Form 8-KQNCX · Form 8-K · 2026-08-17
Q2 Loss and Going Concern Warning at Liberty Defense
ProForm 6-KDETX · Form 6-K · 2026-08-17
XORTX Reports $2.5M Loss, Going Concern Warning, and Material Weakness
ProForm 6-KXRTX · Form 6-K · 2026-08-17
CEO Steven Urvan Discloses 27.5% Stake and New 13M-Share Warrant
Form SCHEDULE 13D/APOWW · Form SCHEDULE 13D/A · 2026-08-15
Magnetar Sells $1.56 Trillion in CoreWeave Call Options
ProForm 4CRWV · Form 4 · 2026-08-15
Magnetar Sells $213.8M of CoreWeave Stock, Trimming Stake to 16.9M Shares
Form 4CRWV · Form 4 · 2026-08-15
Magnetar Financial Sells $14.2 Trillion in CoreWeave Call Options
ProForm 4CRWV · Form 4 · 2026-08-15
Magnetar Sells $231.6M of CoreWeave Stock
Form 4CRWV · Form 4 · 2026-08-15
Calisa's Amended S-4 Reveals Updated Pro Forma Financials and Revised Projections for Goodvision Merger
ProForm S-4/AALIS · Form S-4/A · 2026-08-15
CEO Sells $2.9M in Stock; $2.05M Debt Converted to Shares
ProForm 5CAST · Form 5 · 2026-08-15
BBCQ Files Full Reincorporation Merger Plans Ahead of August 25 Pasqal Vote
Form DEFA14ABBCQ · Form DEFA14A · 2026-08-15
Diginex Amends Resulticks Deal to $1.05B, Adds $70M Funding Conditions and Warrant Cancellations
ProForm 6-KDGNX · Form 6-K · 2026-08-15